Vertex Pharmaceuticals Stock Technical Analysis

VRTX Stock  USD 400.76  0.00  0.00%   
As of the 25th of April, Vertex Pharmaceuticals has the Risk Adjusted Performance of (0.05), variance of 1.46, and Coefficient Of Variation of (1,191). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vertex Pharmaceuticals, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Vertex Pharmaceuticals, which can be compared to its competition. Please validate Vertex Pharmaceuticals standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if Vertex Pharmaceuticals is priced more or less accurately, providing market reflects its prevalent price of 400.76 per share. Given that Vertex Pharmaceuticals has information ratio of (0.16), we advise you to double-check Vertex Pharmaceuticals's current market performance to make sure the company can sustain itself at a future point.

Vertex Pharmaceuticals Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Vertex, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Vertex
  
Vertex Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Vertex Pharmaceuticals Analyst Consensus

Target PriceAdvice# of Analysts
388.67Buy33Odds
Vertex Pharmaceuticals current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Vertex analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Vertex stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Vertex Pharmaceuticals, talking to its executives and customers, or listening to Vertex conference calls.
Vertex Analyst Advice Details
Vertex Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vertex Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vertex Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Vertex Pharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Vertex Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Vertex Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Vertex Pharmaceuticals. You can use it to identify possible trend reversals for Vertex Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Vertex Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Vertex Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Vertex Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of   0.57  , which may suggest that Vertex Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 12233.85, which is the sum of squared deviations for the predicted Vertex Pharmaceuticals price change compared to its average price change.

About Vertex Pharmaceuticals Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Vertex Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Vertex Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Vertex Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Vertex Pharmaceuticals. By analyzing Vertex Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Vertex Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Vertex Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2023 2024 (projected)
Dividend Yield0.0018020.0020730.001969
Price To Sales Ratio7.4710.6610.12

Vertex Pharmaceuticals April 25, 2024 Technical Indicators

Most technical analysis of Vertex help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Vertex from various momentum indicators to cycle indicators. When you analyze Vertex charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether Vertex Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vertex Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vertex Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vertex Pharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Global Correlations
Find global opportunities by holding instruments from different markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.181
Earnings Share
13.88
Revenue Per Share
38.297
Quarterly Revenue Growth
0.093
Return On Assets
0.1317
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.